What is a correction dose for a patient with diabetes, specifically using Basalog (insulin glargine) and Fiasp (insulin aspart), who is planning to fast during Ramadan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Correction Dose in Diabetes Management During Ramadan?

A correction dose (also called a supplemental or bolus dose) is an additional amount of rapid-acting insulin administered to bring elevated blood glucose levels back into target range, separate from the scheduled mealtime insulin doses.

Understanding Correction Doses

A correction dose is calculated based on:

  • Current blood glucose level measured by finger stick or continuous glucose monitoring 1
  • Target blood glucose range (typically aiming for time in range >70% during Ramadan) 1
  • Insulin sensitivity factor (how much 1 unit of insulin lowers blood glucose in that individual)

The correction dose is given using rapid-acting insulin like Fiasp (insulin aspart) when blood glucose exceeds target levels, particularly after the Iftar (sunset) meal when hyperglycemia commonly occurs 1, 2.

Specific Application During Ramadan Fasting

For patients using Basalog (insulin glargine) as basal insulin and Fiasp (insulin aspart) as rapid-acting insulin:

Basal Insulin Adjustment

  • Give 60% of the total pre-Ramadan daily insulin dose as insulin glargine in the evening 2
  • The remaining 40% should be divided as rapid-acting insulin (Fiasp) between Suhur (predawn meal) and Iftar (sunset meal) 2

Correction Dose Strategy

  • Automated insulin delivery systems can automatically administer correction doses to manage hyperglycemia after Iftar, providing the highest level of safety 1
  • Manual correction doses with Fiasp should be given when blood glucose rises above target, particularly in the 2 hours following Iftar when postprandial hyperglycemia is most common 1, 2
  • Break the fast immediately if blood glucose drops below 70 mg/dL 1
  • Consider breaking the fast and give correction dose if blood glucose exceeds 300 mg/dL to prevent diabetic ketoacidosis 2, 3

Critical Monitoring Requirements

Self-monitor blood glucose intensively during the first 3-4 weeks of Ramadan, focusing on:

  • First few hours after starting the fast 1, 4
  • Late afternoon before breaking fast 1, 4
  • Post-Iftar (2+ hours after the sunset meal) to detect hyperglycemia requiring correction 1
  • Pre-Suhur (before the predawn meal) 1

Common Pitfalls to Avoid

Excessive insulin reduction risks hyperglycemia and diabetic ketoacidosis 1, 5. While reducing basal insulin is necessary, being too conservative with correction doses after Iftar can lead to prolonged hyperglycemia.

Avoid overcorrecting hypoglycemia with excessive carbohydrate intake, which then requires large correction doses and creates a cycle of glucose variability 6.

Do not administer correction doses if blood glucose is trending downward or within 3-4 hours of the next scheduled insulin dose to prevent insulin stacking and subsequent hypoglycemia 1.

Enhanced Safety with Technology

Continuous glucose monitoring significantly improves safety by providing real-time data for dynamic insulin adjustments, allowing for more precise correction dosing decisions and minimizing severe glycemic events 1.

Flash glucose monitoring systems (like FreeStyle Libre) effectively mitigate hypoglycemia risk when combined with structured dose adjustment protocols 6.

References

Guideline

Medication Adjustments During Ramadan for Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diabetic emergencies including hypoglycemia during Ramadan.

Indian journal of endocrinology and metabolism, 2012

Guideline

Management of Diabetes During Ramadan

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Management for Ramadan Fasting in Patients with Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.